Biofrontera AG Sponsored ADR 10Y Revenue Growth (CAGR)

10Y Revenue Growth (CAGR) of BFAGY for past 10 years: annual, quarterly and twelve month trailing (TTM) including 10Y Revenue Growth (CAGR) growth rates and interactive chart.


Highlights and Quick Summary

  • Annual 10Y Revenue Growth (CAGR) for 2021 was 17.51% (a -3.9% decrease from previous year)
  • Annual 10Y Revenue Growth (CAGR) for 2021 was 18.22% (a -222.28% decrease from previous year)
  • Annual 10Y Revenue Growth (CAGR) for 2016 was -14.9% (a -3.31% decrease from previous year)
Visit stockrow.com/BFAGY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical 10Y Revenue Growth (CAGR) of Biofrontera AG Sponsored ADR

Most recent 10Y Revenue Growth (CAGR)of BFAGY including historical data for past 10 years.

Interactive Chart of 10Y Revenue Growth (CAGR) of Biofrontera AG Sponsored ADR

Biofrontera AG Sponsored ADR 10Y Revenue Growth (CAGR) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 17.51%
2016 -14.9%

Business Profile of Biofrontera AG Sponsored ADR

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic